Comparison of the Effect of Dietary and Herbal Supplements on Anthropometric, Metabolic and Androgenic Profiles of Women with Polycystic Ovary Syndrome: a Systematic Review and Network Meta-analysis Protocol

Overview

Journal J Turk Ger Gynecol Assoc

Publisher Galenos Publishing House

Specialty Gynecology & Obstetrics

Date 2023 Dec 6

PMID 38054419

Authors

Sumanta Saha

Sujata Saha

Affiliations

Soon will be listed here.

Abstract

Polycystic ovarian syndrome (PCOS) is characterized by obesity, glucose intolerance, dyslipidemia, and hyperandrogenemia. Although several, placebo-controlled 2x2 factorial design, randomized controlled trials have tested the efficacy of dietary and herbal supplements in controlling these parameters in PCOS patients, these studies are not suitable for a comparative efficacy assessment across these supplements. Herein, a protocol for systematic review and network meta-analysis (NMA) is presented to make such a comparison. PubMed, Embase, and Scopus, were interrogated to identify relevant trials, published in English, factors to be investigated will include dietary factors, micronutrients, choline, essential fatty acids, and herbal extracts. Other factors to be considered include trial design, population characteristics, interventions compared, and outcomes of interest. The revised Cochrane tool was used for the appraisal of eligible trials. NMA (frequentist method) will be used for respective outcomes to compare effect sizes (weighted or standardized mean difference) among the interventions. Both logical and statistical (inconsistency assessment) approaches will be used to minimize intransitivity risk. The surface under the cumulative ranking curve values will be used to gauge the best intervention for outcomes with a statistically significant effect size suggesting a favorable outcome. Additionally, the exploration of interrelation among interventions and the small study effect in respective NMA models will be investigated using network maps and comparison-adjusted funnel plots, respectively. Statistical significance is assumed at p<0.05 with 95% confidence interval. Stata statistical software (v16) was used for analysis. The study was registered with PROSPERO, registration number: CRD42022301530.

References

Amini L, Mojab F, Jahanfar S, Sepidarkish M, Raoofi Z, Maleki-Hajiagha A . Efficacy of Salvia officinalis extract on the prevention of insulin resistance in euglycemic patients with polycystic ovary syndrome: A double-blinded placebo-controlled clinical trial. Complement Ther Med. 2020; 48:102245. DOI: 10.1016/j.ctim.2019.102245. View

Khorshidi M, Moini A, Alipoor E, Rezvan N, Gorgani-Firuzjaee S, Yaseri M . The effects of quercetin supplementation on metabolic and hormonal parameters as well as plasma concentration and gene expression of resistin in overweight or obese women with polycystic ovary syndrome. Phytother Res. 2018; 32(11):2282-2289. DOI: 10.1002/ptr.6166. View

Rouse B, Chaimani A, Li T . Network meta-analysis: an introduction for clinicians. Intern Emerg Med. 2016; 12(1):103-111. PMC: 5247317. DOI: 10.1007/s11739-016-1583-7. View

Talbott E, Clerici A, Berga S, Kuller L, Guzick D, Detre K . Adverse lipid and coronary heart disease risk profiles in young women with polycystic ovary syndrome: results of a case-control study. J Clin Epidemiol. 1998; 51(5):415-22. DOI: 10.1016/s0895-4356(98)00010-9. View

Jamilian M, Zadeh Modarres S, Amiri Siavashani M, Karimi M, Mafi A, Ostadmohammadi V . The Influences of Chromium Supplementation on Glycemic Control, Markers of Cardio-Metabolic Risk, and Oxidative Stress in Infertile Polycystic ovary Syndrome Women Candidate for In vitro Fertilization: a Randomized, Double-Blind, Placebo-Controlled.... Biol Trace Elem Res. 2018; 185(1):48-55. DOI: 10.1007/s12011-017-1236-3. View

Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A . Rayyan-a web and mobile app for systematic reviews. Syst Rev. 2016; 5(1):210. PMC: 5139140. DOI: 10.1186/s13643-016-0384-4. View

Haidari F, Banaei-Jahromi N, Zakerkish M, Ahmadi K . The effects of flaxseed supplementation on metabolic status in women with polycystic ovary syndrome: a randomized open-labeled controlled clinical trial. Nutr J. 2020; 19(1):8. PMC: 6982376. DOI: 10.1186/s12937-020-0524-5. View

De Frene V, Vansteelandt S, TSjoen G, Gerris J, Somers S, Vercruysse L . A retrospective study of the pregnancy, delivery and neonatal outcome in overweight versus normal weight women with polycystic ovary syndrome. Hum Reprod. 2014; 29(10):2333-8. DOI: 10.1093/humrep/deu154. View

Moran L, Noakes M, Clifton P, Wittert G, Williams G, Norman R . Short-term meal replacements followed by dietary macronutrient restriction enhance weight loss in polycystic ovary syndrome. Am J Clin Nutr. 2006; 84(1):77-87. DOI: 10.1093/ajcn/84.1.77. View

10.

Dumesic D, Oberfield S, Stener-Victorin E, Marshall J, Laven J, Legro R . Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome. Endocr Rev. 2015; 36(5):487-525. PMC: 4591526. DOI: 10.1210/er.2015-1018. View

11.

Moran L, Brinkworth G, Noakes M, Norman R . Effects of lifestyle modification in polycystic ovarian syndrome. Reprod Biomed Online. 2006; 12(5):569-78. DOI: 10.1016/s1472-6483(10)61182-0. View

12.

Perera R, Heneghan C . Interpreting meta-analysis in systematic reviews. Evid Based Med. 2008; 13(3):67-9. DOI: 10.1136/ebm.13.3.67. View

13.

Saha S . Death and invasive mechanical ventilation risk in hospitalized COVID-19 patients treated with anti-SARS-CoV-2 monoclonal antibodies and/or antiviral agents: A systematic review and network meta-analysis protocol. PLoS One. 2022; 17(6):e0270196. PMC: 9205473. DOI: 10.1371/journal.pone.0270196. View

14.

Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M . Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ. 2015; 350:g7647. DOI: 10.1136/bmj.g7647. View

15.

Lim S, Hutchison S, Van Ryswyk E, Norman R, Teede H, Moran L . Lifestyle changes in women with polycystic ovary syndrome. Cochrane Database Syst Rev. 2019; 3:CD007506. PMC: 6438659. DOI: 10.1002/14651858.CD007506.pub4. View

16.

Glenny A, Altman D, Song F, Sakarovitch C, Deeks J, DAmico R . Indirect comparisons of competing interventions. Health Technol Assess. 2005; 9(26):1-134, iii-iv. DOI: 10.3310/hta9260. View

17.

Cote M, Lubowitz J, Brand J, Rossi M . Understanding Network Meta-analysis (NMA) Conclusions Requires Scrutiny of Methods and Results: Introduction to NMA and the Geometry of Evidence. Arthroscopy. 2021; 37(7):2013-2016. DOI: 10.1016/j.arthro.2021.04.070. View

18.

Winters S, Talbott E, Guzick D, ZBOROWSKI J, McHugh K . Serum testosterone levels decrease in middle age in women with the polycystic ovary syndrome. Fertil Steril. 2000; 73(4):724-9. DOI: 10.1016/s0015-0282(99)00641-x. View

19.

Papilloud A, Guillot de Suduiraut I, Zanoletti O, Grosse J, Sandi C . Peripubertal stress increases play fighting at adolescence and modulates nucleus accumbens CB1 receptor expression and mitochondrial function in the amygdala. Transl Psychiatry. 2018; 8(1):156. PMC: 6093900. DOI: 10.1038/s41398-018-0215-6. View

20.

Song F, Altman D, Glenny A, Deeks J . Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses. BMJ. 2003; 326(7387):472. PMC: 150178. DOI: 10.1136/bmj.326.7387.472. View